Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VOR
VOR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VOR News
Vor Biopharma Reports Q4 2025 Net Income Surge
Mar 30 2026
seekingalpha
Latest Wall Street Rating Updates
Mar 30 2026
CNBC
RPT-VOR BIOPHARMA REPORTS Q4 NET INCOME OF USD 1,722.8 MILLION, SURPASSING IBES ESTIMATE OF USD -28.9 MILLION
Mar 30 2026
moomoo
VOR Biopharma Inc: Jefferies Begins Coverage with a Buy Rating and Sets Target Price at $50
Mar 30 2026
moomoo
VOR Biopharma Stock Increases by 1.5% Following $75 Million Private Placement
Mar 27 2026
moomoo
Vor Bio Secures $75M in Private Placement Financing
Mar 27 2026
seekingalpha
Vor Bio Secures $75 Million in Private Placement Financing
Mar 27 2026
Newsfilter
Vor Biopharma Appoints Two New Board Members to Support $150M PIPE Financing
Dec 23 2025
Globenewswire
Vor Bio Secures $150 Million in Private Placement at $10.81 per Share
Dec 15 2025
Newsfilter
J.P. Morgan Initiates Coverage on Lead Asset with Overweight Rating, Boosting Bio Shares
Dec 09 2025
SeekingAlpha
Vor Biopharma (VOR) Receives Upgrade to Buy: Key Information You Need to Know
Nov 25 2025
NASDAQ.COM
HC Wainwright & Co. Upholds Buy Rating for Vor Biopharma (VOR)
Nov 15 2025
NASDAQ.COM
HC Wainwright & Co. Reaffirms Buy Rating for Vor Biopharma, Adjusts Price Target to $32
Nov 14 2025
Benzinga
Dow Rises Over 300 Points; Energy Vault Holdings Stock Soars
Nov 11 2025
Benzinga
Vor Biopharma Raises $100 Million Following Positive Kidney Disease Trial Results
Nov 11 2025
Benzinga
US Stocks Show Varied Performance; Sea Shares Rise Following Q3 Earnings Report
Nov 11 2025
Benzinga
Show More News
